The Department of Health – Abu Dhabi (DoH) and Boehringer Ingelheim, one of the worlds leading biopharmaceutical companies, have entered into a strategic collaboration leveraging Abu Dhabi’s advanced genomics ecosystem to help shape the future of precision medicine in the UAE. The Memorandum o. .



